Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Uterine Cervical Neoplasms 1Thrombocythemia, Essential 1Prostatic Neoplasms 1Primary Myelofibrosis 1Polycythemia Vera 1Breast Neoplasms 1

Interventions

Cyclophosphamide 10fludarabine phosphate 9Peripheral Blood Stem Cell Transplantation 8Cyclosporine 8Mycophenolic Acid 6Busulfan 6Filgrastim 5Antilymphocyte Serum 5Radiotherapy 4Psychiatric Rehabilitation 4Methotrexate 4fludarabine 3Whole-Body Irradiation 3Tacrolimus 3Melphalan 3Flow Cytometry 3Cord Blood Stem Cell Transplantation 3Aprepitant 3thymoglobulin 2Therapeutics 2Ondansetron 2Methylprednisolone 2Dexamethasone 2Calcium Dobesilate 2Analgesia 2sargramostim 1merphos 1dexamethasone acetate 1dexamethasone 21-phosphate 1Voriconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Primary Myelofibrosis × Diagnosis × Clear all
NCT03121599 2020-08-11

18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms

Hamad Medical Corporation

Phase NA Terminated
3 enrolled
Myeloid

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡